https://www.prnewswire.com/news-releases/pathios-therapeutics-highlights-role-of-gpr65-as-critical-innate-immune-checkpoint-in-the-human-tumor-microenvironment-and-reports-anti-tumor-activity-of-gpr65-inhibition-during-podium-presentation-at-aacr-2022-301523210.html
Pathios Therapeutics Highlights Role of GPR65 as Critical Innate Immune Checkpoint in the Human...
/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today...